National Research Corporation General and Administrative Expenses 2011-2026 | NRC

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses National Research Corporation

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
46.6 M	42.7 M	39 M	34.4 M	33 M	31.4 M	29.7 M	28.4 M	27.2 M	25 M	25.2 M	23.5 M	23.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
46.6 M	23.3 M	31.5 M

Quarterly General and Administrative Expenses National Research Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
12.3 M	17.7 M	10.4 M	-	11 M	11.2 M	11.2 M	-	11.8 M	12 M	11.8 M	-	10.8 M	10.7 M	10.6 M	-	9.52 M	10 M	9.52 M	-	7.95 M	8.85 M	8.75 M	-	8.71 M	8.32 M	7.71 M	-	7.68 M	7.94 M	7.87 M	-	8.43 M	6.9 M	6.69 M	-	7.14 M	7.27 M	7.36 M	-	6.62 M	6.64 M	7.63 M	-	5.8 M	5.98 M	6.37 M	-	6.02 M	6.39 M	6.49 M	-	5.82 M	5.57 M	6.15 M	-	5.57 M	5.99 M	6.09 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
17.7 M	5.57 M	8.47 M

General and Administrative Expenses of other stocks in the Diagnostics research industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	46.7 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	2.08 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	16.2 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	39.2 M	-	-61.36 %	$ 2.46 M	USA
Brainsway Ltd. BWAY	5.78 M	$ 23.08	1.7 %	$ 99.4 M	Israel
Burning Rock Biotech Limited BNR	490 M	$ 29.14	-3.75 %	$ 326 M	China
Biocept BIOC	16.1 M	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	51.9 M	$ 1.1	0.46 %	$ 1.4 M	USA
Check-Cap Ltd. CHEK	9.46 M	-	-	$ 9.42 M	Israel
Oxford Immunotec Global PLC OXFD	22.3 M	-	-	$ 562 M	Britain
Co-Diagnostics CODX	14.3 M	-	-	$ 79.8 M	USA
DarioHealth Corp. DRIO	18.1 M	$ 11.38	1.16 %	$ 323 M	Israel
DexCom DXCM	1.29 B	$ 70.29	8.0 %	$ 27.4 B	USA
Celcuity CELC	9.06 M	$ 103.65	-1.16 %	$ 4.09 B	USA
Chembio Diagnostics CEMI	24.3 M	-	0.22 %	$ 16.8 M	USA
Castle Biosciences CSTL	200 M	$ 32.89	3.09 %	$ 914 M	USA
Danaher Corporation DHR	7.76 B	$ 211.14	-1.74 %	$ 154 B	USA
Quest Diagnostics Incorporated DGX	1.77 B	$ 205.13	-0.82 %	$ 22.8 B	USA
Global Cord Blood Corporation CO	187 M	-	-	$ 399 M	China
Fluidigm Corporation FLDM	97.9 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	3.83 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	126 M	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	88.1 M	$ 23.24	1.18 %	$ 703 M	USA
PRA Health Sciences, Inc. PRAH	453 M	-	-	$ 10.7 B	USA
Enzo Biochem ENZ	21.7 M	-	-8.98 %	$ 14.8 K	USA
CareDx, Inc CDNA	118 M	$ 19.6	2.62 %	$ 1.05 B	USA
DermTech DMTK	43.8 M	-	-11.32 %	$ 2.94 M	USA
Interpace Biosciences IDXG	9.49 M	$ 1.85	-	$ 8.12 M	USA
Exact Sciences Corporation EXAS	191 M	$ 103.32	0.09 %	$ 19.1 B	USA
Heska Corporation HSKA	64.1 M	-	-	$ 1.31 B	USA
Lantheus Holdings LNTH	194 M	$ 68.71	-0.02 %	$ 4.75 B	USA
Guardant Health GH	180 M	$ 104.76	1.95 %	$ 12.9 B	USA
QIAGEN N.V. QGEN	128 M	-	-	$ 10.6 B	Niderland
HTG Molecular Diagnostics HTGM	15.8 M	-	-20.0 %	$ 1.06 M	USA
Charles River Laboratories International CRL	751 M	$ 160.2	0.91 %	$ 8.23 B	USA
IDEXX Laboratories IDXX	442 M	$ 627.58	1.68 %	$ 51.8 B	USA
Illumina ILMN	1.09 B	$ 115.9	1.27 %	$ 18.4 B	USA
OPKO Health OPK	304 M	$ 1.24	2.48 %	$ 861 M	USA
IQVIA Holdings IQV	1.99 B	$ 166.72	-1.27 %	$ 30.2 B	USA
Natera NTRA	589 M	$ 204.66	-1.53 %	$ 20.1 B	USA
Koninklijke Philips N.V. PHG	599 M	$ 31.11	-0.94 %	$ 20 B	Niderland
Biodesix BDSX	80.5 M	$ 11.55	6.6 %	$ 1.5 B	USA
Personalis PSNL	46.2 M	$ 8.22	-2.09 %	$ 487 M	USA
Laboratory Corporation of America Holdings LH	2.23 B	$ 281.39	1.13 %	$ 23.6 B	USA
ICON Public Limited Company ICLR	585 M	$ 95.34	19.06 %	$ 7.86 B	Irlanda
Quidel Corporation QDEL	66.6 M	$ 23.61	-0.55 %	$ 995 M	USA
Biomerica BMRA	2.98 M	$ 2.25	4.19 %	$ 5.17 M	USA
Bioventus BVS	304 M	$ 8.22	1.48 %	$ 515 M	USA
Medpace Holdings MEDP	198 M	$ 429.09	3.14 %	$ 12.4 B	USA